Deep learning CT signature for predicting early liver metastases in pancreatic ductal adenocarcinoma

Predicting the risk of early liver micrometastases (ELM) is crucial for identifying patients who are most likely to benefit from neoadjuvant therapy (NAT) in pancreatic ductal adenocarcinoma (PDAC) yet most deep learning models focus mainly on primary tumours…